Clinical Trials - Sarcoma

 TRIAL

 PHASE  CONTACT  LOCATION
 

Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma (Alliance A091102)

 II

Deborah Meyer, RN, BGS dmeyerk@unmc.edu 

(402) 559-6941or Rose Hoyt

-----------------------------

Rebecca Hadenfeldt, RN, BSN

RHadenfeldt@sfmc-gi.org

P: 308-398-6783

F: 309-398-3219

 

 

Nebraska Medical Center, Omaha, NE;

Saint Francis Cancer Treatment Center, Grand Island, NE

 

AEWS1031 A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of

Non-Metastatic Ewing Sarcoma

 III

Deborah Meyer, RN, BGS

 

dmeyerk@unmc.edu

 (402) 559-6941 or Tamra Olson

 Nebraska Medical Center, Omaha, NE
 

ARST0921, A Randomized Phase II Trial of Bevacizumab (IND# 7921, Avastin) and Temsirolimus (IND# 61010, Torisel) in Combination with

Intravenous Vinorelbine and Cyclophosphamide in Patients with Recurrent/ Refractory Rhabdomyosarcoma (UNMC 597-11)

 II  

Deborah Meyer, RN, BGS

 

dmeyerk@unmc.edu

 (402) 559-6941 or Tamra Olson

 Nebraska Medical Center, Omaha, NE
       

Nebraska Oncology Society
c/o Nebraska Medical Association
Sarah Dunbar
Executive Director
233 South 13th Street Suite 1200
Lincoln, NE 68508
sarahd@nebmed.org (email)
402-474-4472 (phone)
402-474-2198 (fax)

Powered by Wild Apricot Membership Software